CN104257913A - 治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 - Google Patents
治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 Download PDFInfo
- Publication number
- CN104257913A CN104257913A CN201410504750.2A CN201410504750A CN104257913A CN 104257913 A CN104257913 A CN 104257913A CN 201410504750 A CN201410504750 A CN 201410504750A CN 104257913 A CN104257913 A CN 104257913A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine
- water
- agent
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 208000004396 mastitis Diseases 0.000 title claims abstract description 20
- 239000011248 coating agent Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 241000411851 herbal medicine Species 0.000 claims abstract description 8
- 239000000865 liniment Substances 0.000 claims description 27
- 229940040145 liniment Drugs 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 10
- 239000003390 Chinese drug Substances 0.000 claims description 9
- 239000004014 plasticizer Substances 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 4
- -1 Polyethylene Polymers 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 14
- 239000011505 plaster Substances 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 239000002552 dosage form Substances 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 description 20
- 239000001963 growth medium Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 6
- 210000005075 mammary gland Anatomy 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000006981 Skin Abnormalities Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000193985 Streptococcus agalactiae Species 0.000 description 2
- 241000194042 Streptococcus dysgalactiae Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000010579 first pass effect Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011120 smear test Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 229940115920 streptococcus dysgalactiae Drugs 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 208000031462 Bovine Mastitis Diseases 0.000 description 1
- 206010006312 Breast swelling Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂。优点一是中草药经过对有效成分提取,药物纯,无其它成分,无其它副作用;药效足,疗效好。二是成膜剂的加入,改变了传统乳房中草药膏药的剂型,既保留了传统中草药膏药给药方法的独特优点,又使药物使用简单、方便。三是药液中加入皮肤护理剂,使用药部位乳房皮肤得到保护,减少其不良反应。
Description
技术领域
本发明涉及一种用于治疗奶牛乳房炎的中药浓缩液,本发明还涉及一种由该中药浓缩液制备的涂膜剂。
背景技术
乳房炎是奶牛生产中最常见的一种疾病,是由多种因素导致的乳腺组织的一种抵抗性炎症反应,以病原微生物侵入乳腺引起的乳房炎占大部分,其主要病理变化是乳腺组织的泌乳障碍和乳腺组织的病变,危害大,损失严重。西药在乳房炎治疗上具有诸多缺点,如有的抗生素疗效不佳,抗生素的残留影响消费者的健康,频繁的使用抗生素容易使细菌耐药,导致再次治疗更加困难。而中草药作为纯天然药物,含有各种生物有效成分,不易产生耐药性,体内代谢较快,高效低毒,无残留;它不仅具有抗菌、抗病毒作用,还具有调节机体机能的作用,通过活血化淤,化淤散结,散结消肿,舒肝解郁,清热解毒,通经下乳,加上按摩、热敷可以促进血液循环,增强机体抵抗力,抑制病原微生物繁殖,从而促进炎症消散和组织修复。
临床上用于治疗奶牛乳房炎的中药制剂多为散剂、煎剂、注射剂。散剂和煎剂通过拌料或开水灌服,给药方便,但用量大,成本高,药物在瘤胃内有一定损失,且因肝脏的首过效应会影响疗效;中药注射剂作用迅速,但制备工艺繁琐且不易稳定,给药操作严格,乳池内灌注时易造成乳腺损伤。外用药膏是提取药物有效成分,浓缩后制成膏剂,采用涂抹方式给药,药物直接到达病所,药物经乳房皮肤吸收首先进入乳腺组织,并维持较高、恒定的血药浓度,延长作用时间,充分发挥药效,可以不经过肝脏的“首过效应”和胃肠道的破坏,不受胃肠道酶、消化液、PH值的影响,达到一定的血药浓度,提高生物利用度,减少给药次数,降低药物毒性和副作用,提高疗效。
用中草药制成膏药涂抹乳房治疗奶牛乳腺炎,尤其是对发热、肿胀、肿块等症状明显的乳房炎有着它药物与其不可比拟的优势,治疗效果非常明显。传统膏药的制作过程十分烦琐复杂,炼制时毒烟燎绕,容易发生事故,且火侯难以把握,炼出的膏药不老就嫩,坏膏弃膏的情况经常发生,而且含有重金属和铅等毒素,对机体不利,且容易过敏发痒,起泡或皮疹,副作用大;另外传统膏药制作时将药物经过高温油炸后,致使药物中的有效成份被破坏或丧失,其疗效则会大打折扣;其含有一定量的油脂,有助于药物之间的结合,及与皮肤的黏贴,但对涂抹处处理困难。
发明内容
本发明要解决的技术问题在于提供一种用于治疗奶牛乳房炎的中药浓缩液,本发明要解决的技术问题在于提供一种由该浓缩液制备的涂膜剂。
本发明用于治疗奶牛乳房炎的中药浓缩液由以下组分及重量份配比的中药经过浸泡、煮沸、过滤、浓缩、离心分离制备而成:
由上述浓缩液制备的涂膜剂其原料组成及重量份配比是:
中药浓缩剂 52~57份 成膜剂 30~40份 增塑剂 2~5份
皮肤护理剂 3~6份 表面活性剂 1~3份 透皮剂 5~8份
上述的成膜剂由重量比为2∶1的医药级聚乙烯醇1750和聚乙烯醇1799制成。
上述的皮肤护理剂由重量比为1∶9的水溶性羊毛脂和凡士林制成。
上述的透皮剂由重量比为2∶9的丙二醇和氮酮制成。
上述的表面活性剂为吐温-80。
上述的增塑剂为甘油。
以下是本发明产品的制备方法:
(1)中药浓缩剂:将上述的中草药按重量份混合一起,加8倍水浸泡30min,武火煎煮沸腾后再用文火煎30min,四层纱布过滤,再加4倍水煎煮30min,过滤,合并两次滤液,武火浓缩至药液量为加水总量的1/12,经3000转/min 20min离心,用蒸馏水调至含生药浓度1mg/ml,高压灭菌后冷藏保存备用。
(2)成膜剂:将聚乙烯醇1750和聚乙烯醇1799分别加入6倍的蒸馏水浸泡24小时,96℃水浴加热2.5小时,并不断搅拌至全部溶解,过滤去除杂物,晾凉。再将聚乙烯醇1750水溶液和聚乙烯醇1799水溶液按2∶1的比例混合,制备成本发明的成膜剂。
(3)皮肤护理剂:将羊毛脂与凡士林按1∶9的比例混合,加4倍的蒸馏水,混匀。
(4)透皮剂:将氮酮和丙二醇按2∶9的比例混合,加2倍的蒸馏水,混匀。
(5)增塑剂:将甘油加1倍水稀释,混匀。
(6)表面活性剂:将吐温-80加3倍水稀释,混匀。
(7)将上述六种溶液按重量份配比混合,充分搅拌,混匀即可。
本发明的优点有三个方面,第一是中草药经过对有效成分提取,药物纯,无其它成分,无其它副作用;药效足,疗效好。第二是成膜剂的加入,改变了传统乳房中草药膏药的剂型,既保留了传统中草药膏药给药方法的独特优点,又使药物使用简单、方便。第三是药液中加入皮肤护理剂,使用药部位乳房皮肤得到保护,减少其不良反应。
具体实施例
实施例1
本发明用于治疗奶牛乳房炎的中药浓缩液由以下组分及重量份配比的中药制备而成:
实施例2
本发明用于治疗奶牛乳房炎的中药浓缩液由以下组分及重量份配比的中药制备而成:
实施例3
本发明产品乳房中药涂膜剂是由以下的有效药物组分及重量份配比制备而成的:
中药浓缩剂 52份 成膜剂 38份 增塑剂 4份
皮肤护理剂 5份 表面活性剂 3份 透皮剂 8份
实施例4
本发明产品乳房中药涂膜剂是由以下的有效药物组分及重量份配比制备而成的:
中药浓缩剂 55份 成膜剂 34份 增塑剂 3份
皮肤护理剂 4份 表面活性剂 3份 透皮剂 5份
实施例5
本发明产品乳房中药涂膜剂是由以下的有效药物组分及重量份配比制备而成的:
中药浓缩剂 57份 成膜剂 35份 增塑剂 2份
皮肤护理剂 3份 表面活性剂 2份 透皮剂 7份
实施例6
本发明产品的使用方法:在奶牛乳房肿胀部位喷洒或涂抹即可。
实施例7
本发明产品的质量检测及效果评价:
以下试验使用实施例3、4、5均能达到同样效果。
1、性状
本品为黑色、半透明黏稠状液体。
2、成膜时间试验
将药液涂抹在奶牛乳房上,观察其成膜时间、成膜状态。结果在6min时乳房涂抹部即可形成一层软膜。将膜慢慢揭开,形成的膜弹性较强、完整、成片、无孔洞。
3、稳定性试验
取制备好的乳房中药涂膜剂分装于250ml的玻璃瓶中,分别于室温避光和冰箱(0℃~5℃)储存,每隔7d定期观察。结果12个月内无沉淀、无分层、无变色现象。
4、皮肤刺激性试验
(1)一次涂抹试验:取健康成年兔16只,平均体重为2.6±0.3kg,雌雄不限,分两组,每组8只,剃光背部两侧毛约12cm2,取乳房中药涂膜剂和常水各15ml,分别均匀涂在背部两侧的剃毛处,于给药1、2、4、6、12、24、48、72h时(每一个时间段一只兔)揭下,观察皮肤变化。结果涂抹部均无红疹、水疱等皮肤异常反应。
(2)连续涂抹试验:取另外健康成年兔6只,平均体重为2.3±0.1kg,雌雄不限,分两组,每组3只,剃光家兔背部两侧毛约12cm2,取乳房中药涂膜剂和常水各15ml,分别均匀涂在家兔背部两侧的剃毛处,48h时揭下,隔2天一次,共3次,观察皮肤反应。结果涂抹部均无红疹、水疱等皮肤异常反应。
5、去膜试验
将乳房涂抹处形成的膜,从一边慢慢揭起,可揭下完整的膜,乳房皮肤涂抹处没有任何痕迹。
6、卫生学检验
(1)培养检验:将乳房中药涂膜剂分别加入普通肉汤培养基和琼脂培养基上,放置37℃恒温箱24h后观察培养基的变化。结果普通肉汤培养基内和琼脂培养基上都无细菌生长。
(2)常规保存检验:将乳房中药涂膜剂分装于250ml的玻璃瓶中密封,在常温下避光放置,每隔1个月观察一次。结果24个月内溶液中无任何细菌、真菌等微生物生成,溶液不变质。
7、杀菌效力检验
(1)抑菌试验:将从奶牛乳房炎病料中分离的金黄色葡萄球菌、无乳链球菌、停乳链球菌和大肠杆菌接种于各自适宜的培养基琼脂平板上,每种细菌同时接种2个培养基,然后分I、II两组,每组各有4种不同的培养基,I组加入薄层乳房中药涂膜剂,II组不加乳房中药涂膜剂,放置37℃恒温箱,培养24h后观察细菌的生长情况。
结果见表1。
表1 抑菌试验
结果加入薄层乳房中药涂膜剂的组,各培养基上无细菌生长;不加乳房中药涂膜剂的组,各培养基上有细菌生长。
(2)杀菌试验:将从奶牛乳房炎病料中分离的金黄色葡萄球菌、无乳链球菌、停乳链球菌和大肠杆菌接种于适宜的培养基琼脂平板上,每种细菌同时接种2个培养基,放置37℃恒温箱培养24h后分I、II两组,每组各有4种不同的培养基,I组加入薄层乳房中药涂膜剂,II组不加乳房中药涂膜剂,再放置37℃恒温箱继续培养,24h后观察细菌生长情况。
结果见表2。
表2 杀菌试验
结果加入乳房中药涂膜剂后,细菌停止生长,镜检:细菌死亡;不加乳房中药涂膜剂的培养基上,细菌继续生长,镜检无细菌死亡。
8、临床应用效果试验
(1)试验奶牛黑龙江省天和牧业公司,品种为中国荷斯坦奶牛。选择3~5岁、产犊3~5个月的乳房炎奶牛38头,常规饲养,专人管理,饲料精粗搭配,舍饲与放牧相结合。
(2)试验药品奶牛乳房中药涂膜剂,本所研制生产,批号:20130622。
(3)试验方法在饲养、环境、人员管理、挤奶等相同的情况下,将试验奶牛随机平均分为2组,每组19头,I组为对照组,不用任何药物治疗;II组为治疗组,乳房中药涂膜剂涂抹乳房肿胀部位,24h后揭下,再重新涂抹,连续5次。观察乳房炎发生情况。
(4)结果见表3。
表3 奶牛乳房中药涂膜剂临床应用效果试验
I组奶牛未经治疗,治愈率为零,发病率仍为100%,;II组奶牛经乳房中药涂膜剂治疗,治愈率为89.47%,乳腺炎发病率下降为10.53%。II组比I组效果显著。
Claims (3)
1.一种用于治疗奶牛乳房炎的中药浓缩液,其特征在于:该中药浓缩液由以下组分及重量份配比的中药经过浸泡、煮沸、过滤、浓缩、离心分离制备而成:
。
2.由权利要求1所述用于治疗奶牛乳房炎的中药浓缩液制备的涂膜剂,其特征在于:该涂膜剂的原料组成及重量份配比是:
中药浓缩剂52~57份 成膜剂30~40份 增塑剂2~5份
皮肤护理剂3~6份 表面活性剂1~3份 透皮剂5~8份
上述的成膜剂由重量比为2∶1的医药级聚乙烯醇1750和聚乙烯醇1799制成。
上述的皮肤护理剂由重量比为1∶9的水溶性羊毛脂和凡士林制成。
上述的透皮剂由重量比为2∶9的丙二醇和氮酮制成。
上述的表面活性剂为吐温-80。
上述的增塑剂为甘油。
3.一种如权利要求2所述涂膜剂的制备方法:
(1)中药浓缩剂:将上述的中草药按重量份混合一起,加8倍水浸泡30min,武火煎煮沸腾后再用文火煎30min,四层纱布过滤,再加4倍水煎煮30min,过滤,合并两次滤液,武火浓缩至药液量为加水总量的1/12,经3000转/min20min离心,用蒸馏水调至含生药浓度1mg/ml,高压灭菌后冷藏保存备用。
(2)成膜剂:将聚乙烯醇1750和聚乙烯醇1799分别加入6倍的蒸馏水浸泡24小时,96℃水浴加热2.5小时,并不断搅拌至全部溶解,过滤去除杂物,晾凉。再将聚乙烯醇1750水溶液和聚乙烯醇1799水溶液按2∶1的比例混合,制备成本发明的成膜剂。
(3)皮肤护理剂:将羊毛脂与凡士林按1∶9的比例混合,加4倍的蒸馏水,混匀。
(4)透皮剂:将氮酮和丙二醇按2∶9的比例混合,加2倍的蒸馏水,混匀。
(5)增塑剂:将甘油加1倍水稀释,混匀。
(6)表面活性剂:将吐温-80加3倍水稀释,混匀。
(7)将上述六种溶液按重量份配比混合,充分搅拌,混匀即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410504750.2A CN104257913A (zh) | 2014-09-17 | 2014-09-17 | 治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410504750.2A CN104257913A (zh) | 2014-09-17 | 2014-09-17 | 治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104257913A true CN104257913A (zh) | 2015-01-07 |
Family
ID=52149570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410504750.2A Pending CN104257913A (zh) | 2014-09-17 | 2014-09-17 | 治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104257913A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104922313A (zh) * | 2015-07-16 | 2015-09-23 | 南京天元肽医药科技有限公司 | 一种用于治疗奶牛乳房炎病的药物组合物 |
CN105169023A (zh) * | 2015-09-06 | 2015-12-23 | 王璐 | 一种治疗家畜乳腺病的兽药 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1660209A (zh) * | 2004-12-21 | 2005-08-31 | 江苏省农业科学院 | 治疗奶牛乳房炎的涂膜剂及其制备方法 |
CN101209310A (zh) * | 2006-12-25 | 2008-07-02 | 天津市润拓生物技术有限公司 | 一种用于治疗奶牛乳房炎的复方中药注射剂 |
CN102139024A (zh) * | 2011-03-20 | 2011-08-03 | 赵全会 | 一种用于治疗奶牛乳房炎的中药 |
CN102716431A (zh) * | 2012-07-13 | 2012-10-10 | 宁夏大学 | 一种治疗奶牛乳房炎的中药涂膜剂制备方法 |
-
2014
- 2014-09-17 CN CN201410504750.2A patent/CN104257913A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1660209A (zh) * | 2004-12-21 | 2005-08-31 | 江苏省农业科学院 | 治疗奶牛乳房炎的涂膜剂及其制备方法 |
CN101209310A (zh) * | 2006-12-25 | 2008-07-02 | 天津市润拓生物技术有限公司 | 一种用于治疗奶牛乳房炎的复方中药注射剂 |
CN102139024A (zh) * | 2011-03-20 | 2011-08-03 | 赵全会 | 一种用于治疗奶牛乳房炎的中药 |
CN102716431A (zh) * | 2012-07-13 | 2012-10-10 | 宁夏大学 | 一种治疗奶牛乳房炎的中药涂膜剂制备方法 |
Non-Patent Citations (1)
Title |
---|
梁剑平: "《中兽药学》", 31 January 2014, 军事医学科学出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104922313A (zh) * | 2015-07-16 | 2015-09-23 | 南京天元肽医药科技有限公司 | 一种用于治疗奶牛乳房炎病的药物组合物 |
CN104922313B (zh) * | 2015-07-16 | 2019-08-23 | 山东禹泽医药科技有限公司 | 一种用于治疗奶牛乳房炎病的药物组合物 |
CN105169023A (zh) * | 2015-09-06 | 2015-12-23 | 王璐 | 一种治疗家畜乳腺病的兽药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4026722B2 (ja) | 植物発酵エキス、植物発酵エキス末及び該植物発酵エキス配合物 | |
CN102836367B (zh) | 一种抗菌消炎止痒的中药组合物及其制备方法和应用 | |
RU2624868C2 (ru) | Способ приготовления комплексного гелеобразного препарата для лечения и профилактики мастита у коров и комплексный гелеобразный препарат на его основе | |
CN104257684B (zh) | 奶牛乳头药浴涂膜剂及其制备方法 | |
CN105854021B (zh) | 具有镇痛、抑菌双重效果的外用药物、制剂及其制备方法 | |
CN104288222B (zh) | 一种治疗奶牛子宫内膜炎的纳米药物及其制备方法 | |
US20170112885A1 (en) | Herbal formulations of carnivorous plants and methods for treating inflammation | |
CN104096007B (zh) | 一种山羊应激防控中药组合物及其制备方法 | |
CN104257913A (zh) | 治疗奶牛乳房炎的中药浓缩液及由该浓缩液制备的涂膜剂 | |
KR101835799B1 (ko) | 프로폴리스를 유효성분으로 함유하는 화장품 조성물 및 상기 조성물을 포함하는 화장품 | |
CN103251691B (zh) | 治疗奶牛乳房炎的中药方剂及其提取物和制剂 | |
CN104906132B (zh) | 一种防治羔羊口炎的膏药制剂 | |
CN107137528A (zh) | 防治海马烂尾病的药物及组合物 | |
Ayansola et al. | Apitherapy in Southwestern Nigeria: An assessment of therapeutic potentials of some honeybee products | |
CN103446399B (zh) | 一种治疗痤疮的外用中药面膜制剂及其制造工艺 | |
CN115518026A (zh) | 一种含美洲大蠊的外用兽药及其制备方法和用途 | |
CN105560374A (zh) | 一种用于治疗奶牛乳腺炎的复方制剂及其制备方法 | |
CN101810666B (zh) | 兽用增效恩诺沙星注射液及其制备方法 | |
CN103610709A (zh) | 一种降解水体藻类毒素的组合物及其制备方法 | |
CN103301242B (zh) | 一种中草药组合物在制备防治草鱼虫菌并发综合症复方制剂中的用途 | |
CN108066518A (zh) | 一种犬用中药浴液组合物及其制备方法 | |
CN102210812B (zh) | 一种复方瑞他莫林药物膜剂及其制备方法 | |
CN105963761B (zh) | 一种盐酸溶菌酶创可贴及其制备方法和应用 | |
Mānuka et al. | 14 Mind Blowing Uses of Manuka Honey! | |
CN104906131A (zh) | 一种防治羔羊口炎膏药制剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150107 |